Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System
<p>Mesenchymal stromal cells (MSCs), formerly known as mesenchymal stem cells, are nonhematopoietic multipotent cells and are emerging worldwide as the most clinically used and promising source for allogeneic cell therapy. MSCs, initially obtained from bone marrow, can be derived from several...
Saved in:
| Main Author: | Bella S. Guerrouahen (14153289) (author) |
|---|---|
| Other Authors: | Heba Sidahmed (2632471) (author), Asma Al Sulaiti (14590691) (author), Moza Al Khulaifi (14166135) (author), Chiara Cugno (3441302) (author) |
| Published: |
2019
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CXCR7 signaling promotes breast cancer survival in response to mesenchymal stromal stem cell-derived factors
by: Mashael Al-toub (3563303)
Published: (2022) -
Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGFβ and focal adhesion kinase (FAK) signaling
by: Radhakrishnan Vishnubalaji (3563306)
Published: (2019) -
A Systems-level Characterization of the Differentiation of Human Embryonic Stem Cells into Mesenchymal Stem Cells*[S]
by: Anja M. Billing (1297773)
Published: (2019) -
Aberrant development of pancreatic beta cells derived from human iPSCs with FOXA2 deficiency
by: Ahmed K. Elsayed (13275302)
Published: (2022) -
Identification of potential transcription factors that enhance human iPSC generation
by: Nuha T. Swaidan (18595219)
Published: (2020)